APH vs OGEN · P/E 40, rev $23.09B vs rev $37.7K
Amphenol Corporation (APH) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the APH and OGEN stock pages for the full models.
Not investment advice.